Shardlow CE[au] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2001	1
2011	1
2013	1
2022	0

Page 1

Impact of physiologically based pharmacokinetic modeling and simulation in drug development.

Shardlow CE, Generaux GT, Patel AH, Tai G, Tran T, Bloomer JC. Shardlow CE, et al. Drug Metab Dispos. 2013 Dec;41(12):1994-2003. doi: 10.1124/dmd.113.052803. Epub 2013 Sep 5. Drug Metab Dispos. 2013. PMID: 24009310

Utilizing drug-drug interaction prediction tools during drug development: enhanced decision making based on clinical risk.

Shardlow CE, Generaux GT, MacLauchlin CC, Pons N, Skordos KW, Bloomer JC. Shardlow CE, et al. Drug Metab Dispos. 2011 Nov;39(11):2076-84. doi: 10.1124/dmd.111.039214. Epub 2011 Aug 10. Drug Metab Dispos. 2011. PMID: 21832001

Pharmacokinetics of the novel, high-affinity and selective dopamine D3 receptor antagonist SB-277011 in rat, dog and monkey: in vitro/in vivo correlation and the role of aldehyde oxidase.

Austin NE, Baldwin SJ, Cutler L, Deeks N, Kelly PJ, Nash M, Shardlow CE, Stemp G, Thewlis K, Ayrton A, Jeffrey P. Austin NE, et al. Among authors: shardlow ce. Xenobiotica. 2001 Aug-Sep;31(8-9):677-86. doi: 10.1080/00498250110056531. Xenobiotica. 2001. PMID: 11569533

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results